Global Prenatal Testing Market

Report Highlights

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Report Includes

• 37 data tables and 52 additional tables
• An overview of the current and future global markets for prenatal testing
• Analyses of global market trends, with historical revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
• Estimates of the current market size and revenue growth prospects, along with a market share analysis by technology and product types, application, end users and region
• Discussion of the market opportunities and challenges, ongoing R&D efforts and regulatory scenarios
• A look at emerging technologies related to prenatal testing
• Overview of the sustainability trends and ESG developments, with emphasis on consumer attitudes, companies’ ESG rankings and their ESG practices
• Insight into the competitive landscape, including company market shares, financials and revenues
• Profiles of the leading players, including Illumina Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Natera Inc., and F. Hoffmann-La Roche Ltd.

Report Scope

The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies and methodologies employed to assess fetal health during pregnancy. Genetic testing plays a central role, encompassing a range of approaches from traditional invasive procedures, such as amniocentesis and chorionic villus sampling to modern noninvasive methods, such as noninvasive prenatal testing (NIPT). This market is characterized by its global reach, with varying levels of adoption and accessibility across different regions. The focus is predominantly on screening for genetic disorders, including chromosomal abnormalities and hereditary conditions. The rise of comprehensive testing strategies evaluating multiple biomarkers enhances diagnostic accuracy. The market is driven by increasing maternal age, heightened awareness of genetic disorders and technological advancements. Ongoing research and development (R&D) efforts continue to shape the scope of prenatal testing, with a strong emphasis on improving accuracy and accessibility and incorporating innovative diagnostic and screening procedures. It presents insights into current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this helpful study.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.